Cyclerion Therapeutics (CYCN) Assets (2019 - 2025)
Cyclerion Therapeutics (CYCN) has disclosed Assets for 7 consecutive years, with $10.4 million as the latest value for Q3 2025.
- For Q3 2025, Assets rose 17.05% year-over-year to $10.4 million; the TTM value through Sep 2025 reached $10.4 million, up 17.05%, while the annual FY2024 figure was $9.6 million, 28.41% down from the prior year.
- Assets hit $10.4 million in Q3 2025 for Cyclerion Therapeutics, up from $9.4 million in the prior quarter.
- Across five years, Assets topped out at $100.0 million in Q1 2021 and bottomed at $8.9 million in Q3 2024.
- Average Assets over 5 years is $28.8 million, with a median of $13.4 million recorded in 2023.
- Year-over-year, Assets crashed 75.38% in 2023 and then increased 17.05% in 2025.
- Cyclerion Therapeutics' Assets stood at $59.3 million in 2021, then plummeted by 69.53% to $18.1 million in 2022, then dropped by 26.02% to $13.4 million in 2023, then fell by 28.41% to $9.6 million in 2024, then rose by 8.77% to $10.4 million in 2025.
- According to Business Quant data, Assets over the past three periods came in at $10.4 million, $9.4 million, and $9.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.